- Home
- SHBI vs KURA Comparison
SHBI vs KURA Comparison
Compare SHBI & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SHBI
- KURA
- Stock Information
- Founded
- SHBI 1876
- KURA 2014
- Country
- SHBI United States
- KURA United States
- Employees
- SHBI N/A
- KURA N/A
- Industry
- SHBI Major Banks
- KURA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SHBI Finance
- KURA Health Care
- Exchange
- SHBI Nasdaq
- KURA Nasdaq
- Market Cap
- SHBI 548.7M
- KURA 561.9M
- IPO Year
- SHBI N/A
- KURA N/A
- Fundamental
- Price
- SHBI $15.77
- KURA $6.30
- Analyst Decision
- SHBI Buy
- KURA Strong Buy
- Analyst Count
- SHBI 2
- KURA 12
- Target Price
- SHBI $20.00
- KURA $24.50
- AVG Volume (30 Days)
- SHBI 155.3K
- KURA 1.3M
- Earning Date
- SHBI 07-24-2025
- KURA 08-07-2025
- Dividend Yield
- SHBI 3.00%
- KURA N/A
- EPS Growth
- SHBI 169.44
- KURA N/A
- EPS
- SHBI 1.61
- KURA N/A
- Revenue
- SHBI $208,209,000.00
- KURA $67,991,000.00
- Revenue This Year
- SHBI N/A
- KURA $125.04
- Revenue Next Year
- SHBI $7.22
- KURA $83.75
- P/E Ratio
- SHBI $9.94
- KURA N/A
- Revenue Growth
- SHBI 24.24
- KURA N/A
- 52 Week Low
- SHBI $11.47
- KURA $5.41
- 52 Week High
- SHBI $17.61
- KURA $21.57
- Technical
- Relative Strength Index (RSI)
- SHBI 45.41
- KURA 51.17
- Support Level
- SHBI $15.60
- KURA $6.15
- Resistance Level
- SHBI $16.84
- KURA $6.74
- Average True Range (ATR)
- SHBI 0.42
- KURA 0.30
- MACD
- SHBI -0.15
- KURA -0.00
- Stochastic Oscillator
- SHBI 13.71
- KURA 33.38
About SHBI Shore Bancshares Inc
Shore Bancshares Inc is a financial holding company. It offers personalized banking, insurance, and investment services to families and businesses in the Mid-Atlantic region. It operates in one business segment- banking. The company's primary source of revenue is derived from interest earned on commercial, residential mortgage and other loans, and fees charged in connection with lending and other banking services located in Maryland, Delaware and Virginia.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.